Clincosm LogoSign in Get a demo

Alzheimer's Disease

Showing 1 - 25 of 904
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer's Disease Trial in Israel, United Kingdom (IBC-Ab002, Placebo)

Not yet recruiting
  • Alzheimer's Disease
  • IBC-Ab002
  • Placebo
  • Haifa, Israel
  • +5 more
Sep 20, 2022

Alzheimer's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease, Healthy Volunteers Trial in Wuhan ([18F]APN-1607)

Recruiting
  • Alzheimer's Disease
  • +2 more
  • Wuhan, Hubei, China
    Union Hospital Tongji Medical College Huazhong University of Sci
Sep 13, 2022

Alzheimer's Disease Trial in Worldwide (Placebo, Bepranemab)

Recruiting
  • Alzheimer's Disease
  • Placebo
  • Bepranemab
  • Sun City, Arizona
  • +115 more
Aug 18, 2022

Cognitive Health in Ageing Register: Investigational,

Active, not recruiting
  • Alzheimer's Disease
  • Plaque, Amyloid
    • Edinburgh, United Kingdom
    • +1 more
    Aug 17, 2022

    Alzheimer's Disease Trial in United States (Remternetug (IV), Remternetug (SC), Placebo)

    Recruiting
    • Alzheimer's Disease
    • Remternetug (IV)
    • +2 more
    • Chandler, Arizona
    • +70 more
    Aug 10, 2022

    Alzheimer's Disease Trial in United States (Aducanumab, Placebo)

    Recruiting
    • Alzheimer's Disease
    • Santa Ana, California
    • +19 more
    Aug 9, 2022

    Alzheimer's Disease Trial in United States (Posiphen, Placebo)

    Active, not recruiting
    • Alzheimer's Disease
    • La Jolla, California
    • +5 more
    Aug 1, 2022

    Alzheimer's Disease Trial in United States (MK-8189, Placebo)

    Recruiting
    • Alzheimer's Disease
    • Cutler Bay, Florida
    • +4 more
    Aug 1, 2022

    Alzheimer's Disease Trial in Heidelberg, Shepparton, West Perth (SLS-005, Placebo)

    Not yet recruiting
    • Alzheimer's Disease
    • Heidelberg, Victoria, Australia
    • +2 more
    Jul 31, 2022

    Alzheimer's Disease, Mild Cognitive Impairment Trial in Australia, United States (Donepezil, Placebo)

    Recruiting
    • Alzheimer's Disease
    • Mild Cognitive Impairment
    • Long Beach, California
    • +9 more
    Aug 1, 2022

    Alzheimer's Disease Trial (TB006)

    Not yet recruiting
    • Alzheimer's Disease
    • (no location specified)
    Jul 25, 2022

    Alzheimer's Disease, Prodromal Alzheimer's Disease, Amyloid Plaque Trial in Liverpool, London (Placebo, ACI-24.060 at Dose A,

    Recruiting
    • Alzheimer's Disease
    • +4 more
    • Placebo
    • +6 more
    • Liverpool, United Kingdom
    • +1 more
    Jul 13, 2022

    Alzheimer's Disease Trial in Roskilde (Light Therapy System (LTS): Active Setting, Light Therapy System (LTS): Sham Setting)

    Not yet recruiting
    • Alzheimer's Disease
    • Light Therapy System (LTS): Active Setting
    • Light Therapy System (LTS): Sham Setting
    • Roskilde, Denmark
      Zealand University Hospital
    Jun 27, 2022

    Alzheimer's Disease Trial in Toulouse (NanoLithium® NP03, Placebo)

    Recruiting
    • Alzheimer's Disease
    • NanoLithium® NP03
    • Placebo
    • Toulouse, France
      CHU Toulouse - Hôpital La Grave - Cité de la Santé
    Jun 14, 2022

    Dementia, Alzheimer's Disease, Dementia Prevention Trial in La Jolla (HALT-AD)

    Active, not recruiting
    • Dementia
    • +2 more
    • HALT-AD
    • La Jolla, California
      Alzheimer's Disease Cooperative Study (ADCS)
    May 25, 2022

    Alzheimer's Disease Trial in Worldwide (BIIB092, Placebo)

    Terminated
    • Alzheimer's Disease
    • Birmingham, Alabama
    • +100 more
    May 20, 2022

    Alzheimer's Disease Trial in Kansas City (Creatine Monohydrate)

    Not yet recruiting
    • Alzheimer's Disease
    • Creatine Monohydrate
    • Kansas City, Kansas
      University of Kansas Medical Center
    May 16, 2022

    Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis

    Recruiting
    • Alzheimer's Disease
      • Beijing, Beijing, China
        Xuanwu Hospital of Capital Medical University
      May 5, 2022

      Alzheimer's Disease Trial in Decatur (AL 001, Placebo)

      Recruiting
      • Alzheimer's Disease
      • AL 001
      • Placebo
      • Decatur, Georgia
        iResearch Atlanta & iResearch Savannah
      May 5, 2022

      Alzheimer's Disease Trial in Montréal (Eye-Tracking)

      Recruiting
      • Alzheimer's Disease
      • Eye-Tracking
      • Montréal, Quebec, Canada
        The Douglas Research Centre
      May 3, 2022

      Alzheimer's Disease Trial in Gilbert, Palmetto Bay, Papillion (simufilam)

      Enrolling by invitation
      • Alzheimer's Disease
      • Gilbert, Arizona
      • +2 more
      Apr 26, 2022

      Mild Cognitive Impairment, Alzheimer's Disease Trial in Australia (Xanamem® 5 mg, Placebo, Xanamem® 10 mg)

      Completed
      • Mild Cognitive Impairment
      • Alzheimer's Disease
      • Xanamem® 5 mg
      • +2 more
      • Bruce, Australian Capital Territory, Australia
      • +4 more
      Apr 6, 2022

      Alzheimer's Disease, Aging Trial in Madison (Enhanced Physical Activity)

      Completed
      Has Results
      • Alzheimer's Disease
      • Aging
      • Enhanced Physical Activity
      • Madison, Wisconsin
        University of Wisconsin School of Medicine and Public Health
      Apr 1, 2022

      Effect of REST in the Alzheimer Disease Continuum

      Completed
      • Alzheimer's Disease
        • Beijing, Beijing, China
          Dongzhimen Hospital,Beijing University of Chinese Medicine
        Mar 22, 2022

        Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)

        Terminated
        Has Results
        • Alzheimer's Disease
        • Birmingham, Alabama
        • +132 more
        Feb 16, 2022